GET THE APP
jcsr

Journal of Cancer Science and Research

ISSN - 2576-1447

+44 1478 350008

Trastuzumab

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.  It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin. Common side effects include fever, infection, cough, headache, trouble sleeping, and rash. Other severe side effects include heart failure, allergic reactions, and lung disease. Use during pregnancy may harm the baby.  Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Journal Highlights

Journal Flyer

Flyer
Top